A detailed history of Eagle Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 1,468,962 shares of MRK stock, worth $146 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
1,468,962
Previous 1,472,330 0.23%
Holding current value
$146 Million
Previous $182 Million 8.48%
% of portfolio
1.0%
Previous 1.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $374,353 - $434,370
-3,368 Reduced 0.23%
1,468,962 $167 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $3.37 Million - $3.62 Million
27,197 Added 1.88%
1,472,330 $182 Million
Q1 2024

May 09, 2024

SELL
$113.24 - $131.95 $19.8 Million - $23 Million
-174,657 Reduced 10.78%
1,445,133 $191 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $4.62 Million - $5.03 Million
-46,127 Reduced 2.77%
1,619,790 $177 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $7.9 Million - $8.77 Million
-76,713 Reduced 4.4%
1,665,917 $172 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $3.93 Million - $4.29 Million
-36,208 Reduced 2.04%
1,742,630 $201 Million
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $4.67 Million - $5.21 Million
45,360 Added 2.62%
1,778,838 $189 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $799,026 - $1.02 Million
9,138 Added 0.53%
1,733,478 $192 Million
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $29.3 Million - $32.9 Million
346,694 Added 25.17%
1,724,340 $149 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $26.2 Million - $29.7 Million
-313,569 Reduced 18.54%
1,377,646 $126 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $9.19 Million - $10.3 Million
-124,984 Reduced 6.88%
1,691,215 $139 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $6.65 Million - $8.33 Million
92,031 Added 5.34%
1,816,199 $140 Million
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $1.04 Million - $1.15 Million
14,535 Added 0.85%
1,724,168 $130 Million
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $2.11 Million - $2.33 Million
-30,024 Reduced 1.73%
1,709,633 $133 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $87.5 Million - $103 Million
1,271,074 Added 271.26%
1,739,657 $134 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $94.3 Million - $105 Million
-1,314,602 Reduced 73.72%
468,583 $38.3 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $26.3 Million - $29.8 Million
359,611 Added 25.26%
1,783,185 $146 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $18.3 Million - $20.9 Million
-260,557 Reduced 15.47%
1,423,574 $108 Million
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $130,901 - $181,436
2,066 Added 0.12%
1,684,131 $130 Million
Q4 2019

Feb 07, 2020

BUY
$77.58 - $87.54 $1.82 Million - $2.05 Million
23,414 Added 1.41%
1,682,065 $153 Million
Q3 2019

Nov 04, 2019

SELL
$76.08 - $82.93 $14 Million - $15.3 Million
-184,276 Reduced 10.0%
1,658,651 $140 Million
Q2 2019

Aug 05, 2019

BUY
$69.84 - $81.59 $5.57 Million - $6.51 Million
79,823 Added 4.53%
1,842,927 $155 Million
Q1 2019

May 01, 2019

BUY
$69.58 - $79.36 $8.7 Million - $9.92 Million
124,982 Added 7.63%
1,763,104 $147 Million
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $1.22 Million - $1.42 Million
18,691 Added 1.15%
1,638,122 $125 Million
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $1.12 Million - $1.32 Million
-19,425 Reduced 1.19%
1,619,431 $115 Million
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $8.67 Million - $10.2 Million
-170,641 Reduced 9.43%
1,638,856 $99.5 Million
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $115,067 - $133,741
-2,258 Reduced 0.12%
1,809,497 $98.6 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $40.5 Million - $48.3 Million
784,009 Added 76.28%
1,811,755 $101 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $60.3 Million - $64.9 Million
1,027,746
1,027,746 $66.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.